Evidence supporting the use of: Somatropin
For the body system: Pituitary

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Somatropin is a recombinant form of human growth hormone (GH) that is scientifically validated for use in supporting the pituitary body system, particularly in conditions of growth hormone deficiency. The pituitary gland is responsible for producing endogenous growth hormone, which is crucial for growth, metabolism, and tissue repair. When the pituitary fails to produce adequate GH, as seen in conditions like hypopituitarism or isolated growth hormone deficiency, somatropin is administered as a replacement therapy.

Multiple randomized controlled trials and decades of clinical practice have demonstrated the efficacy of somatropin in promoting linear growth in children with GH deficiency and improving body composition, bone density, and quality of life in adults with GH deficiency. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved somatropin for these indications based on robust scientific evidence.

Somatropin therapy is not based on tradition, but rather on a clear understanding of pituitary physiology and direct clinical evidence. Its use is limited to specific pituitary-mediated hormone deficiencies and is not indicated for general enhancement in healthy individuals. In summary, somatropin is a scientifically validated therapy with strong evidence (rated 5/5) for supporting the pituitary body system in cases of deficient endogenous growth hormone production.

More about Somatropin
More about Pituitary

Products containing Somatropin

We currently have no products on Vitabase that contain this ingredient.